Every article and medication profile on MyGLPTalk is written and medically reviewed by Ian Gauntt, a registered nurse with a Bachelor of Science in Nursing.
Ian's nursing background is in direct patient care, where much of the day-to-day work is translation: taking what a prescription, a lab result, or a discharge plan actually means and explaining it in words a patient can act on. MyGLPTalk applies that same discipline to GLP-1 medications — a space where hype and fear routinely outrun the evidence.
What Ian covers here
- How GLP-1 medications (semaglutide, tirzepatide, liraglutide) work, and what the trials actually show.
- Nutrition and intermittent fasting alongside a reduced appetite — protecting muscle, energy, and nutrient intake.
- Exercise during medication-assisted weight loss.
- Women's health on GLP-1 therapy, where the evidence base is thinner and the trade-offs land differently.
How the review process works
Drafts are researched with the help of AI tools, then Ian verifies every clinical claim against its primary source — FDA prescribing information or the peer-reviewed literature — before anything is published. Pages show their review date, and corrections are made promptly when readers flag an error. The full process is described in the editorial policy.
A note on scope
Nothing here is individual medical advice. Ian is a nurse, not your nurse — use this site to have better conversations with the clinician who knows your history.
Reach Ian at hello@myglptalk.com.